GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jacobio Pharmaceuticals Group Co Ltd (STU:77V) » Definitions » YoY EPS Growth

Jacobio Pharmaceuticals Group Co (STU:77V) YoY EPS Growth : 109.68% (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Jacobio Pharmaceuticals Group Co YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Jacobio Pharmaceuticals Group Co's YoY EPS Growth for the quarter that ended in Dec. 2024 was 109.68%.

Jacobio Pharmaceuticals Group Co's Earnings per Share (Diluted) for the six months ended in Dec. 2024 was €0.00.

Jacobio Pharmaceuticals Group Co YoY EPS Growth Historical Data

The historical data trend for Jacobio Pharmaceuticals Group Co's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jacobio Pharmaceuticals Group Co YoY EPS Growth Chart

Jacobio Pharmaceuticals Group Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
YoY EPS Growth
Get a 7-Day Free Trial -593.06 88.78 -17.86 10.61 55.93

Jacobio Pharmaceuticals Group Co Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -38.71 -16.67 27.91 - 109.68

Jacobio Pharmaceuticals Group Co YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Jacobio Pharmaceuticals Group Co's YoY EPS Growth for the fiscal year that ended in Dec. 2024 is calculated as:

YoY EPS Growth (A: Dec. 2024 )
=(Earnings per Share (Diluted) (A: Dec. 2024 )-Earnings per Share (Diluted) (A: Dec. 2023 ))/ | Earnings per Share (Diluted) (A: Dec. 2023 ) |
=(-0.026--0.059)/ | -0.059 |
=55.93 %

Jacobio Pharmaceuticals Group Co's YoY EPS Growth for the quarter that ended in Dec. 2024 is calculated as:

YoY EPS Growth (Q: Dec. 2024 )
=(Earnings per Share (Diluted) (Q: Dec. 2024 )-Earnings per Share (Diluted) (Q: Dec. 2023 )) / | Earnings per Share (Diluted) (Q: Dec. 2023 )) |
=(0.003--0.031)/ | -0.031 |
=109.68 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jacobio Pharmaceuticals Group Co YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Jacobio Pharmaceuticals Group Co's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Jacobio Pharmaceuticals Group Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jacobio Pharmaceuticals Group Co Ltd (STU:77V) » Definitions » YoY EPS Growth
Comparable Companies
HKSE:01873 HKSE:01541 HKSE:02179 HKSE:02509 HKSE:01521 HKSE:02616 HKSE:06660 HKSE:06978 HKSE:02487 HKSE:02181 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
01167:Hong Kong
Address
No. 88, Kechuang 6th Street, Building F2, Beijing Economic-Technological Development Area, Beijing, CHN
Website
https://www.jacobiopharma.com
Jacobio Pharmaceuticals Group Co Ltd is a clinical-stage pharmaceutical company focusing on the in-house discovery and development of innovative oncology therapies.

Jacobio Pharmaceuticals Group Co Headlines

No Headlines